Home | Welcome to Contract Pharma   
Last Updated Thursday, April 2 2015


Topics - Biologics, Proteins, Vaccines

Refine by Date:
From: To:
Published March 30, 2015
Merck Serono gains access to Intrexon's suite of technologies to engineer T-cells Read More »
Published March 26, 2015
Fully operational to supply comprehensive immunotherapeutic treatments Read More »
Published March 25, 2015
Will receive as much as £652,000 to expand bioproduction research Read More »
Published March 23, 2015
To develop targeted anticancer therapeutics for as many as two undisclosed targets Read More »
Published March 16, 2015
Manufactures MVA EBOZ for Phase I trial Read More »
Published March 12, 2015
Will provide cGMP manufacture for clinical and commercial supply Read More »
Published March 9, 2015
Sandoz Zarxio approved for all indications on Filgrastim label Read More »
Published March 6, 2015
CoE in San Diego has 46,000 sq.-ft. of lab, office and sample storage space Read More »
Published March 2, 2015
Integrates continuous flow manufacturing technology Read More »
Published February 25, 2015
Opens newly expanded office Read More »
Published February 24, 2015
Will manufacture AB-022 for the treatment of cardiovascular diseases Read More »
Published February 23, 2015
Will develop TGF beta receptor kinase inhibitors Read More »
Published February 23, 2015
Expands immuno-oncology pipeline Read More »
Published February 23, 2015
Secures long-term lease in Bannockburn, IL Read More »
Published February 23, 2015
BBSRC competition invests £20M to bring innovative biotechnology projects to market Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On